Publications by authors named "T Munoz-Antonia"

Introduction: Incidence of endometrial cancer (EC) in Hispanic/Latina (H/L) women are higher compared to other race/ethnicities in the United States. EC is the third most common cancer and the fourth cause of cancer-related deaths in Puerto Rican women, yet demographic and clinical information is limited. High rates of EC risk factors such as obesity, diabetes mellitus type 2 (DM2) and hypertension (HTN) have been documented in the Puerto Rican population.

View Article and Find Full Text PDF
Article Synopsis
  • The study analyzed breast cancer patients in four different groups: non-Hispanic Whites, non-Hispanic Blacks, Hispanics in Florida, and Hispanics in Puerto Rico.
  • Significant disparities were found, with Puerto Rican women having the lowest employment and education levels, along with a higher incidence of advanced tumors and fewer survival rates compared to the other groups.
  • The research highlights the urgent need for further investigation into the factors contributing to these health disparities among Puerto Rican and non-Hispanic Black breast cancer patients.
View Article and Find Full Text PDF

Unlabelled: Ancestrally diverse and admixed populations, including the Hispanic/Latino/a/x/e community, are underrepresented in cancer genetic and genomic studies. Leveraging the Latino Colorectal Cancer Consortium, we analyzed whole exome sequencing data on tumor/normal pairs from 718 individuals with colorectal cancer (128 Latino, 469 non-Latino) to map somatic mutational features by ethnicity and genetic ancestry. Global proportions of African, East Asian, European, and Native American ancestries were estimated using ADMIXTURE.

View Article and Find Full Text PDF

Background: Lung cancer biomarker-driven therapies are the gold standard of treatment and recent studies suggest a higher prevalence of specific targetable biomarkers among Hispanic/Latinos (H/L) than Non-Hispanic Whites (NHW). The study aimed (1) to identify Florida (FL) and Puerto Rico (PR) physicians' knowledge and perceived value of newer genomic data regarding race/ethnicity in relation to optimal lung cancer treatment and survival; and (2) to identify modifiable practice barriers both across and within each location regarding biomarker testing in lung cancer.

Methods: A 25-item survey was administered to a stratified random sample of physicians in FL and PR (medical oncologists, radiation oncologists, pulmonologists, and pathologists).

View Article and Find Full Text PDF